Cure My Disease

Don't miss your cure!

 Log in / Sign up

MS drug delivery showdown: belly vs. thigh, pen vs. syringe

NCT ID NCT07503873

Recruiting now Disease control Sponsor: TG Therapeutics, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 4 times

Summary

This study tests a drug called ublituximab, given as a shot under the skin, in 350 people with relapsing multiple sclerosis. Researchers want to see how the drug moves through the body when injected in different spots (like the belly or thigh) and whether an autoinjector pen works as well as a regular syringe. The goal is to find the safest and most convenient way to give the medicine.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multiple sclerosis relapsing-remitting multiple sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MULTIPLE SCLEROSIS

Contacts and locations

Locations

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Bihać, 77000, Bosnia and Herzegovina

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Sarajevo, 71000, Bosnia and Herzegovina

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Tuzla, 75000, Bosnia and Herzegovina

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Zenica, 72000, Bosnia and Herzegovina

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Tbilisi, 101, Georgia

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Tbilisi, 114, Georgia

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Tbilisi, 159, Georgia

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Tbilisi, 179, Georgia

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Shtip, 2000, North Macedonia

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Skopje, 1000, North Macedonia

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Bydgoszcz, 85-796, Poland

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Katowice, 40-568, Poland

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Katowice, 40-686, Poland

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Kielce, 25-726, Poland

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Lodz, 90-324, Poland

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Poznan, 61-853, Poland

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Warsaw, 04-141, Poland

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Belgrade, 11000, Serbia

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Kragujevac, 34 000, Serbia

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Chernihiv, 14001, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Chernihiv, 14029, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Ivano-Frankivsk, 76008, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Ivano-Frankivsk, 76018, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Ivano-Frankivsk, 76493, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Kyiv, 2000, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Kyiv, 2091, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Kyiv, 3037, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Kyiv, 3110, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Kyiv, 4050, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Kyiv, 4211, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Lviv, 79010, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Lviv, 79029, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Odesa, 65009, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Poltava, 36011, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Tbilisi, 159, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Ternopil, 46014, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Uzhhorod, 88018, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Vinnytsia, 21001, Ukraine

  • TG Therapeutics Investigational Trial Site

    RECRUITING

    Vinnytsia, 21009, Ukraine

More trials for these conditions

Other studies related to the condition(s) this trial covers.